Develops noninvasive MRI biomarkers to distinguish Alzheimer's disease, Parkinson's disease, mild cognitive impairment, and related neurodegenerative conditions.

Applies functional MRI, cortical-thickness analysis, arterial-spin labeling, vascular imaging, and hippocampal perfusion measures to characterize early disease-related brain changes.